Modulation of intracellular glutathione affects adipogenesis in 3T3-L1 cells

Paola Vigilanza, Katia Aquilano, Sara Baldelli, Giuseppe Rotilio, Maria Rosa Ciriolo

Research output: Contribution to journalArticle

Abstract

Impairment of redox homeostasis has been extensively associated with obesity, as a consequence of the chronic inflammatory state present in overweight subjects. Deregulation of glutathione (GSH), the most important non-enzymatic intracellular anti-oxidant, induces insulin resistance in mature adipocytes, but data are lacking about its effects on adipogenesis. In this report we demonstrate that during adipogenesis of 3T3-L1 cells the GSH/GSSG ratio decreases, shifting redox status towards oxidizing conditions. Moreover, we demonstrate that inhibition of GSH synthesis, obtained by treatment with L-buthionine-sulfoximine (BSO), enhances C/EBPβ LAP/LIP ratio and PPARγ expression during mitotic clonal expansion (MCE) stimulating adipogenesis. On the contrary, GSH ethyl ester (GSHest) supplementation completely abrogates this process also in the presence of BSO. GSH decrement during the first 24h of adipogenesis is sufficient to induce higher triglyceride accumulation in differentiated adipocytes with respect to control, whereas GSHest treatment inhibits lipid droplets formation. We further demonstrate that Resveratrol (RV) could exert anti-adipogenic properties also by increasing GSH content through γ-glutamyl-cysteine ligase (GCL) induction. Overall data indicate that in pre-adipocytes the decrease of GSH accelerates adipogenesis, suggesting that the use of agents able to maintain GSH redox status in adipose tissue, such as RV, could be promising in stopping the lipogenic loop of obesity.

Original languageEnglish
Pages (from-to)2016-2024
Number of pages9
JournalJournal of Cellular Physiology
Volume226
Issue number8
DOIs
Publication statusPublished - Aug 2011

Fingerprint

3T3-L1 Cells
Adipogenesis
Buthionine Sulfoximine
Glutathione
Modulation
Adipocytes
Esters
Oxidation-Reduction
Peroxisome Proliferator-Activated Receptors
Deregulation
Glutathione Disulfide
Ligases
Oxidants
Obesity
Cysteine
Triglycerides
Insulin
Tissue
Lipids
Insulin Resistance

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

Modulation of intracellular glutathione affects adipogenesis in 3T3-L1 cells. / Vigilanza, Paola; Aquilano, Katia; Baldelli, Sara; Rotilio, Giuseppe; Ciriolo, Maria Rosa.

In: Journal of Cellular Physiology, Vol. 226, No. 8, 08.2011, p. 2016-2024.

Research output: Contribution to journalArticle

Vigilanza, Paola ; Aquilano, Katia ; Baldelli, Sara ; Rotilio, Giuseppe ; Ciriolo, Maria Rosa. / Modulation of intracellular glutathione affects adipogenesis in 3T3-L1 cells. In: Journal of Cellular Physiology. 2011 ; Vol. 226, No. 8. pp. 2016-2024.
@article{326560ec4b5e4bab86cb62584e13038b,
title = "Modulation of intracellular glutathione affects adipogenesis in 3T3-L1 cells",
abstract = "Impairment of redox homeostasis has been extensively associated with obesity, as a consequence of the chronic inflammatory state present in overweight subjects. Deregulation of glutathione (GSH), the most important non-enzymatic intracellular anti-oxidant, induces insulin resistance in mature adipocytes, but data are lacking about its effects on adipogenesis. In this report we demonstrate that during adipogenesis of 3T3-L1 cells the GSH/GSSG ratio decreases, shifting redox status towards oxidizing conditions. Moreover, we demonstrate that inhibition of GSH synthesis, obtained by treatment with L-buthionine-sulfoximine (BSO), enhances C/EBPβ LAP/LIP ratio and PPARγ expression during mitotic clonal expansion (MCE) stimulating adipogenesis. On the contrary, GSH ethyl ester (GSHest) supplementation completely abrogates this process also in the presence of BSO. GSH decrement during the first 24h of adipogenesis is sufficient to induce higher triglyceride accumulation in differentiated adipocytes with respect to control, whereas GSHest treatment inhibits lipid droplets formation. We further demonstrate that Resveratrol (RV) could exert anti-adipogenic properties also by increasing GSH content through γ-glutamyl-cysteine ligase (GCL) induction. Overall data indicate that in pre-adipocytes the decrease of GSH accelerates adipogenesis, suggesting that the use of agents able to maintain GSH redox status in adipose tissue, such as RV, could be promising in stopping the lipogenic loop of obesity.",
author = "Paola Vigilanza and Katia Aquilano and Sara Baldelli and Giuseppe Rotilio and Ciriolo, {Maria Rosa}",
year = "2011",
month = "8",
doi = "10.1002/jcp.22542",
language = "English",
volume = "226",
pages = "2016--2024",
journal = "Journal of cellular and comparative physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Modulation of intracellular glutathione affects adipogenesis in 3T3-L1 cells

AU - Vigilanza, Paola

AU - Aquilano, Katia

AU - Baldelli, Sara

AU - Rotilio, Giuseppe

AU - Ciriolo, Maria Rosa

PY - 2011/8

Y1 - 2011/8

N2 - Impairment of redox homeostasis has been extensively associated with obesity, as a consequence of the chronic inflammatory state present in overweight subjects. Deregulation of glutathione (GSH), the most important non-enzymatic intracellular anti-oxidant, induces insulin resistance in mature adipocytes, but data are lacking about its effects on adipogenesis. In this report we demonstrate that during adipogenesis of 3T3-L1 cells the GSH/GSSG ratio decreases, shifting redox status towards oxidizing conditions. Moreover, we demonstrate that inhibition of GSH synthesis, obtained by treatment with L-buthionine-sulfoximine (BSO), enhances C/EBPβ LAP/LIP ratio and PPARγ expression during mitotic clonal expansion (MCE) stimulating adipogenesis. On the contrary, GSH ethyl ester (GSHest) supplementation completely abrogates this process also in the presence of BSO. GSH decrement during the first 24h of adipogenesis is sufficient to induce higher triglyceride accumulation in differentiated adipocytes with respect to control, whereas GSHest treatment inhibits lipid droplets formation. We further demonstrate that Resveratrol (RV) could exert anti-adipogenic properties also by increasing GSH content through γ-glutamyl-cysteine ligase (GCL) induction. Overall data indicate that in pre-adipocytes the decrease of GSH accelerates adipogenesis, suggesting that the use of agents able to maintain GSH redox status in adipose tissue, such as RV, could be promising in stopping the lipogenic loop of obesity.

AB - Impairment of redox homeostasis has been extensively associated with obesity, as a consequence of the chronic inflammatory state present in overweight subjects. Deregulation of glutathione (GSH), the most important non-enzymatic intracellular anti-oxidant, induces insulin resistance in mature adipocytes, but data are lacking about its effects on adipogenesis. In this report we demonstrate that during adipogenesis of 3T3-L1 cells the GSH/GSSG ratio decreases, shifting redox status towards oxidizing conditions. Moreover, we demonstrate that inhibition of GSH synthesis, obtained by treatment with L-buthionine-sulfoximine (BSO), enhances C/EBPβ LAP/LIP ratio and PPARγ expression during mitotic clonal expansion (MCE) stimulating adipogenesis. On the contrary, GSH ethyl ester (GSHest) supplementation completely abrogates this process also in the presence of BSO. GSH decrement during the first 24h of adipogenesis is sufficient to induce higher triglyceride accumulation in differentiated adipocytes with respect to control, whereas GSHest treatment inhibits lipid droplets formation. We further demonstrate that Resveratrol (RV) could exert anti-adipogenic properties also by increasing GSH content through γ-glutamyl-cysteine ligase (GCL) induction. Overall data indicate that in pre-adipocytes the decrease of GSH accelerates adipogenesis, suggesting that the use of agents able to maintain GSH redox status in adipose tissue, such as RV, could be promising in stopping the lipogenic loop of obesity.

UR - http://www.scopus.com/inward/record.url?scp=79955104610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955104610&partnerID=8YFLogxK

U2 - 10.1002/jcp.22542

DO - 10.1002/jcp.22542

M3 - Article

C2 - 21520053

AN - SCOPUS:79955104610

VL - 226

SP - 2016

EP - 2024

JO - Journal of cellular and comparative physiology

JF - Journal of cellular and comparative physiology

SN - 0021-9541

IS - 8

ER -